M4Liver · Application of Metal-organic frameworks synthesized by Microfluidics in Microextraction for Metabolomics: development of a non-invasive bioanalytical method for early diagnosis of fatty Liver diseases
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2023-09-01 → 2025-08-31
- Финансиране от ЕС
- 187 624 €
- Участници
- 1
- Схема
- HORIZON-TMA-MSCA-PF-EF
Линиите свързват координатора с партньорите.
Накратко на български
Метално-органичните рамки се тестват за по-ефективно извличане на разклонени аминокиселини от кръвната плазма. Това помага за разработването на неинвазивен метод за ранна диагностика на неалкохолни стеатозе на черния дроб, който да замени рисковите биопсии.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Application of Metal-organic frameworks synthesized by Microfluidics in Microextraction for Metabolomics: development of a non-invasive bioanalytical method for early diagnosis of fatty Liver diseases
Non-alcoholic fatty liver diseases (NAFLD) are the most common and undiagnosed liver disorders worldwide that can only be diagnosed via risky and complex liver biopsies. The determination of metabolites in biological fluids is one of the most promising alternatives to these invasive procedures. Despite several studies have identified branched amino acids in blood plasma as potential biomarkers, there are a lot of inconsistencies between the results. This is because of the complexity of the analysis given the high hydrophilicity of the amino acids and other metabolites and their low concentration, which hampers their extraction from the plasma and leads to time-consuming and laborious procedures. Thus, there is a need to develop a simple, selective and sensitive analytical method for a reliable diagnosis of NAFLD by detecting key biomarkers. Microextraction techniques are very simple and present high preconcentration, clean-up and sustainability features for sample preparation. There are a few commercially available extraction phases, but they lack selectivity, stability and cannot target highly hydrophilic compounds. In this context, metal-organic frameworks (MOFs) are materials that have attracted much attention because of their high surface area and synthetic tunability, which might lead to better extraction efficiency and tailored selectivity. The M4Liver project aimed to develop a new analytical platform for the direct determination of hydrophilic biomarkers in plasma samples, which can be implemented for the diagnosis of liver diseases. Here, MOFs were systematically studied in terms of extraction capacity and selectivity towards branched amino acids. Then, the MOFs were incorporated in a microextraction device and evaluated for the analysis of plasma samples. Ultimately, the MOF-based microextraction device could be used as a simple and sensitive tool not only for the determination of amino acids, but also for obtaining the metabolomics profile of the samples, which could be expanded for the simple monitoring of other diseases.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder worldwide, which affects to around 25% of the population. It is associated with obesity and diabetes and may lead to chronical liver diseases and cancer. Its diagnosis and prognosis involve a liver biopsy that entails certain unavoidable risks and errors and present a high cost. The determination of biomarkers in biological fluids, particularly metabolomics, is one of the most promising tools as an alternative to these more conventional invasive procedures. Thus, it is important to develop a platform to monitor and diagnose the disease in a wider population as well as to track the disease evolution. The aim of M4Liver project is to design and fabricate an effective microextraction device for the development of a simple and non-invasive bioanalytical method suitable for the early diagnosis, prognosis, and monitoring of fatty liver diseases. The method is based on the identification and quantification of biomarkers in plasma samples. They will be extracted and preconcentrated using a small device coated with a hybrid material with anti-fouling properties, which is composed of a metal-organic framework (MOF) and a polymeric phase. With the aim of ensuring scalability and reproducibility, the MOF particles will be prepared using microfluidics. Overall, the combination of the preconcentration technique, the impressive MOF sorption capacity and polymer stability in this analytical method will contribute to gain insight into the role of biomarkers in NAFLD. Moreover, given the simplicity and the possibility of carrying out parallel and fully automatic analysis with this approach, its implementation in routine clinical laboratories as a simple and economical platform is feasible.
Оригинален текст от CORDIS (на английски).
Участници
- ACADEMISCH ZIEKENHUIS GRONINGEN · GroningenКоординаторНидерландия
Връзки
- Виж в CORDIS
- DOI: 10.3030/101059391
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e503c25512&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e521bb08a6&appId=PPGMS
Данни: CORDIS, © Европейски съюз
